These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28642845)

  • 1. Metabolic Adaptations of Uropathogenic
    Mann R; Mediati DG; Duggin IG; Harry EJ; Bottomley AL
    Front Cell Infect Microbiol; 2017; 7():241. PubMed ID: 28642845
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
    Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
    mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siderophore Biosynthesis Governs the Virulence of Uropathogenic Escherichia coli by Coordinately Modulating the Differential Metabolism.
    Su Q; Guan T; He Y; Lv H
    J Proteome Res; 2016 Apr; 15(4):1323-32. PubMed ID: 26954697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
    mBio; 2012; 3(1):. PubMed ID: 22318320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexible Metabolism and Suppression of Latent Enzymes Are Important for
    Alteri CJ; Himpsl SD; Shea AE; Mobley HLT
    J Bacteriol; 2019 Aug; 201(16):. PubMed ID: 31160397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and Fitness of Urinary Tract Pathogens.
    Alteri CJ; Mobley HLT
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of Arginine Synthesis among Uropathogenic Branches of the Escherichia coli Phylogeny Reveals Adjustment to the Urinary Tract Habitat.
    Hibbing ME; Dodson KW; Kalas V; Chen SL; Hultgren SJ
    mBio; 2020 Sep; 11(5):. PubMed ID: 32994329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.
    Madelung M; Kronborg T; Doktor TK; Struve C; Krogfelt KA; Møller-Jensen J
    BMC Microbiol; 2017 Apr; 17(1):99. PubMed ID: 28438119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.
    Reitzer L; Zimmern P
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31619395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Omic' Approaches to Study Uropathogenic Escherichia coli Virulence.
    Lo AW; Moriel DG; Phan MD; Schulz BL; Kidd TJ; Beatson SA; Schembri MA
    Trends Microbiol; 2017 Sep; 25(9):729-740. PubMed ID: 28550944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract infection drives genome instability in uropathogenic Escherichia coli and necessitates translesion synthesis DNA polymerase IV for virulence.
    Gawel D; Seed PC
    Virulence; 2011; 2(3):222-32. PubMed ID: 21597325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract.
    Vigil PD; Stapleton AE; Johnson JR; Hooton TM; Hodges AP; He Y; Mobley HL
    mBio; 2011; 2(3):e00066-11. PubMed ID: 21540363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uropathogenic Escherichia coli preferentially utilize metabolites in urine for nucleotide biosynthesis through salvage pathways.
    Ma J; Cai X; Bao Y; Yao H; Li G
    Int J Med Microbiol; 2018 Dec; 308(8):990-999. PubMed ID: 30145133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping niche-specific two-component system requirements in uropathogenic
    Brannon JR; Reasoner SA; Bermudez TA; Comer SL; Wiebe MA; Dunigan TL; Beebout CJ; Ross T; Bamidele A; Hadjifrangiskou M
    Microbiol Spectr; 2024 Apr; 12(4):e0223623. PubMed ID: 38385738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.
    Kline KA; Schwartz DJ; Gilbert NM; Hultgren SJ; Lewis AL
    Infect Immun; 2012 Dec; 80(12):4186-94. PubMed ID: 22988014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence properties of uropathogenic Escherichia coli isolated from children with urinary tract infection in Korea.
    Kim DH; Subhadra B; Kang HY; Woo K; Kim J; Son YJ; Sohn KM; Kim HJ; Han K; Oh MH; Choi CH
    Genes Genomics; 2018 Jun; 40(6):625-634. PubMed ID: 29892947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of metabolism in uropathogenic Escherichia coli.
    Chan CCY; Lewis IA
    Trends Microbiol; 2022 Dec; 30(12):1174-1204. PubMed ID: 35941063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli.
    Donovan GT; Norton JP; Bower JM; Mulvey MA
    Infect Immun; 2013 Jan; 81(1):249-58. PubMed ID: 23115037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence and Fitness Determinants of Uropathogenic Escherichia coli.
    Subashchandrabose S; Mobley HLT
    Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.